A Novel Synthesis of 2′-Modified 2′-Deoxy-4′-thiocytidines from D-Glucose

Journal of Organic Chemistry

Volumn 62, Issue 10, 1997, Pages 3140-3152

  Yoshimura, Yuichi ^a   Kitano, Kenji ^a   Yamada, Kohei ^a   Satoh, Hiroshi ^a   Watanabe, Mikari ^a   Miura, Shinji ^a   Sakata, Shinji ^a   Sasaki, Takuma ^b   Matsuda, Akira ^c  

^a YAMASA CORPORATION   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2' DEOXY 2' FLUORO 4' THIOARABINOSYLCYTOSINE; 2' DEOXY 4' THIOCYTIDINE DERIVATIVE; 4' THIOGEMCITABINE; ANTINEOPLASTIC AGENT; CYTARABINE; CYTIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STEREOCHEMISTRY; TUMOR CELL;

EID: 0030917732     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo9700540     Document Type: Article

References (76)

1. A part of this work has appeared: Yoshimura, Y.; Kitano, K.; Satoh, H.; Watanabe, M.; Miura, S.; Sakata, S.; Sasaki, T.; Matsuda, A. J. Org. Chem. 1996, 61, 822-823.
2. Ellison, R. R.; Holland, J. P.; Weil, M.; Jacquillat, C.; Boiron, M.; Bernard, J.; Sawitsky, A.; Rosner, F.; Gussoff, B.; Silver, R. T.; Karanas, A.; Cuttner, J.; Spurr, C. L.; Hayes, D. M.; Blom, J.; Leone, L. A.; Haurani, F.; Kyle, R.; Hutchison, J. L.; Forcíer, R. J.; Moon, J. H. Blood 1968, 32, 507-523.
3. (a) Hertel, L. W.; Kroin, J. S.; Misner, J. W.; Tustin, J. M. J. Org. Chem. 1988, 53, 2406-2409.
4. (b) Hertel, L. W.; Boder, G. B.; Kroin, J. S.; Rinzel, S. M.; Poore, G. A.; Todd, G. C.; Grindey, G. B. Cancer Res. 1990, 50, 4417-4420.
5. (a) Johnston, M. L; Hoth, D. F. Science 1993, 260, 1286-1293.
6. (b) Richman, D. D. Science, 1996, 272, 1886-1888.
7. (a) Schinazi, R. F.; Chu, C. K.; Peck, A.; McMillan, A.; Mathis, R.; Cannon, D.; Jeong, L.-S.; Beach, J. W.; Choi, W.-B.; Yeola, S.; Liotta, D. C. Antimicrob. Agents Chemother. 1992, 36, 672-676.
8. (b) Coates, J. A. V.; Cammack, N.; Jenkinson, H. J.; Jowett, A. J.; Jowett, M. I.; Pearson, B. A.; Penn, C. R.; Rouse, P. L.; Viner, K. C.; Cameron, J. M. Antimicrob. Agents Chemother. 1992, 36, 733-739.
9. (c) Doong, S.-L.; Tsai, C.-H.; Schinazi, R. F.; Liotta, D. C.; Chen, Y.-C. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 8495-8499.
10. (d) Beach, J. W.; Jeong, L. S.; Alves, A J.; Pohl, D.; Kim, H. O.; Chang, C.-N.; Doong, S.-L.; Schinazi, R. F.; Cheng, Y.-C.; Chu, C. K. J. Org. Chem. 1992, 57, 2217-2219.
11. (a) Matsuda, A.; Takenuki, K.; Itoh, H.; Sasaki, T.; Ueda, T. Chem Pharm. Bull. 1987, 35, 3967-3970.
12. (b) Matsuda, A.; Takenuki, K.; Sasaki, T.; Ueda, T. J. Med. Chem. 1991, 34, 234-239.
13. (a) Matsuda, A.; Nakajima, Y.; Azuma, A.; Tanaka, M.; Sasaki, T. J. Med. Chem. 1991, 34, 2917-2919.
14. (b) Tanaka, M.; Matsuda, A.; Terao, T.; Sasaki, T. Cancer Lett. 1992, 64, 67-74.
15. (c) Azuma, A.; Nakajima, Y.; Nishizono, N.; Minakawa, N.; Suzuki, M.; Hanaoka, K.; Kobayashi, T.; Tanaka, M.; Sasaki, T.; Matsuda, A. J. Med. Chem. 1993, 36, 4183-4189.
16. (a) Matsuda, A.; Takenuki, K.; Tanaka, M.; Sasaki, T.; Ueda, T. J. Med. Chem. 1991, 34, 812-819.
17. (b) Yamagami, K.; Fujii, A.; Arita, M.; Okumoto, T.; Sakata, S.; Matsuda, A.; Ueda, T. Cancer Res. 1991, 51, 2319-2323.
18. (c) Ono, T.; Fujii, A.; Yamagami, K.; Hosoya, M.; Okumoto, T.; Sakata, S.; Matsuda, A.; Sasaki, T. Biochem. Pharmacol. 1996, 52, 1279-1285.
19. (a) Bobek, M.; Cheng, Y. C.; Bloch, A. J. Med. Chem. 1978, 21, 597-598.
20. (b) Matsuda, A.; Yasuoka, J.; Sasaki, T.; Ueda, T. J. Med. Chem., 1991, 34, 999-1002.
21. Reist, E. J.; Gueffroy, D. E.; Goodman, L. J. Am. Chem. Soc. 1964, 86, 5658-5663.
22. Reist, E. J.; Fisher, L. V.; Goodman, L. J. Org. Chem. 1968, 33, 189-192.
23. (a) Whistler, R. L.; Doner, L. W.; Nayak, U. G. J. Org. Chem. 1971, 36, 108-110.
24. (b) Bobek, M.; Bloch, A.; Parthasarathy, R.; Whistler, R. L. J. Med. Chem. 1975, 18, 784-787.
25. Ototani, N.; Whistler, R. L. J. Med. Chem. 1974, 17, 535-537.
26. Fu, Y.-L.; Bobek, M. In Nucleic Acid Chemistry; Townsend, L, Tipson, R. S., Eds.; John Wiley & Sons: New York, 1978; pp 317-323.
27. (a) Dyson, M. R.; Coe, P. L.; Walker, R. T. J. Chem. Soc., Chem. Commun. 1991, 741-742.
28. (b) Dyson, M. R.; Coe, P. L.; Walker, R. T. J. Med. Chem. 1991, 34, 2782-2786.
29. Secrist, J. A.; Tiwari, K. N.; Riordan, J. M.; Montgomery, J. A. J. Med. Chem. 1991, 34, 2361-2366.
30. Dyson, M. R.; Coe, P. L.; Walker, R. T. Carbohydr. Res. 1991, 216, 237-248.
31. (a) Uenishi, J.; Motoyama, M.; Nishiyama, Y.; Wakabayashi, S. J. Chem. Soc., Chem. Commun. 1991, 1421-1422.
32. (b) Uenishi, J.; Takahashi, K.; Motoyama, M.; Akashi, H.; Sasaki, T. Nucleosides Nucleotides 1994, 73, 1347-1361.
33. Parks, R. E., Jr.; Stoeckler, J. D.; Cambor, C.; Savarese, T. M.; Crabtree, G. W.; Chu, S.-H. In Molecular Actions and Targets for Cancer Chemotherapeutic Agents; Sartorelli, A. C., Lazo, J. S., Bertino, J. R., Eds.; Academic Press: New York, 1981; pp 229-252.
34. (a) Desgranges, C.; Razaka, G.; Rabaud, M.; Bricaud, H.; Balzarini, J.; De Clercq, E. Biochem. Pharmacol. 1983, 32, 3583-3590.
35. (b) Samuel J.; Gill, M. J.; Iwashima, T.; Tovell, D. R.; Tyrrell, D. L.; Knaus, E. E.; Wiebe, L. I. Antimicrob. Agents Chemother. 1986, 29, 320-324.
36. (a) Rahim, S. G.; Trivedi, N.; Bogunovic-Batchelor, M. V.; Hardy, G. W.; Mills, G.; Selway, J. W. T.; Snowden, W.; Littler, E.; Coe, P. L.; Basnak, I.; Whale, R. F.; Walker, R. T. J. Med. Chem. 1996, 39, 789-795.
37. (b) Van Draanen, N. A.; Freeman, G. A.; Short, S. A.; Harvey, R.; Jansen, R.; Szczech, G.; Koszalka, G. W. J. Med. Chem. 1996, 39, 538-542.
38. (c) Young, R. J.; Shaw-Ponter, S.; Thomson, J. B.; Miller, J. A.; Gumming, J. G.; Pugh, A. W.; Rider, P. Bioorg. Med. Chem. Lett. 1995, 5, 2599-2604.
39. (d) Brånalt, J.; Kvarnström, I.; Niklasson, G.; Svensson, S. C. T.; Classon, B.; Samuelsson, B. J. Org. Chem. 1994, 59, 1783-1788.
40. (e) Tber, B.; Fahmi, N.-E.; Ronco, G.; Villa, P.; Ewing, D. F.; Mackenzie, G. Carbohydr. Res. 1995, 267, 203-215.
41. (a) Bellon, L.; Barascut, J.-L.; Imbach, J.-L. Nucleosides Nucleotides 1992, 11, 1467-1479.
42. (b) Leydier, C.; Bellon, L.; Barascut, J.-L.; Deydier, J.; Maury, G.; Pelicano, H.; El Alaoui, M. A.; Imbach, J.-L. Nucleosides Nucleotides 1994, 13, 2035-2050.
43. Yuasa, H.; Kajimoto, T.; Wong, C.-H. Tetrahedron Lett. 1994, 35, 8243-8246.
44. Yuasa, H.; Tamura, J.; Hashimoto, H. J. Chem. Soc. Perkin Trans. 1 1990, 2763-2769.
45. A 1,4 Pummerer reaction has already been reported: Koppel, G. A.; McShane, L. J. J. Am. Chem. Soc. 1978, 100, 288-289.
46. Booma, C.; Balasubramanian J. Chem. Soc., Chem. Commun. 1993, 1394-1395.
47. Kakefuda, A.; Shuto, S.; Nagahata, T.; Seki, J.; Sasaki, T.; Matsuda, A. Tetrahedron 1994, 507 10167-10182.
48. (a) Kita, Y.; Yasuda, H.; Tamura, O.; Itoh, F.; Tamura, Y. Tetrahedron Lett. 1984, 25, 4681-4682.
49. (b) Kita, Y.; Tamura, O.; Yasuda, H.; Itoh, F.; Tamura, Y. Chem. Pharm. Bull. 1985, 33, 4235-4241.
50. O'Neil, I. A.; Hamilton, K. M. Synlett 1992, 791-792.
51. The stereochemistry at the anomeric carbon was determined by an NOE analysis of the free nucleoside 10 (minor isomer). It showed 7.1% NOE at the H-3′ proton when irradiated H-6.
52. (a) Okabe, M.; Sun, R.-C.; Tam, S. Y.-K.; Todaro, L. J.; Coffen, D. L. J. Org. Chem. 1988, 53, 4780-4786.
53. (b) Brånalt, J.; Kvarnström, I.; Classon, B.; Samuelsson, B. J. Org. Chem. 1996, 61, 3604-3610.
54. (a) Abbruzzese, J. L.; Grunewald, R.; Weeks, E. A.; Gravel, D.; Adams, T.; Nowak, B.; Mineishi, S.; Tarassoff, P.; Satterlee, W.; Raber, M. N.; Plunkett, W. J. Clin. Oncol. 1991, 9, 491-498.
55. (b) Poplin, E. A.; Corbett, T.; Flaherty, L.; Tarassoff, P.; Redman, B. G.; Valdivieso, M.; Baker, L. Invest. New Drugs 1992, 10, 165-170.
56. (c) Lund, B.; Kristjansen, P. E. G.; Hansen, H. H. Cancer Treat. Rev. 1993, 19, 45-55.
57. An, S.-H.; Bobek, M. Tetrahedron Lett. 1986, 27, 3219-3222.
58. Difluoro substituent at the 2′-position potentiates the stability of the glycosidic bond, due to its potent -I effect with destabilizing β-cation.
59. The stereochemistry at the 1′-position was determined, after deprotection, by comparison of coupling constants of H-1′ with that of gemcitabine described in ref 3a.
60. (a) Wright, J. A.; Wilson, D. P.; Fox, J. J. J. Med. Chem. 1970, 13, 269-272.
61. (b) Reichman, U.; Watanabe, K. A.; Fox, J. J. Carbohydr. Res. 1975, 42, 233-240.
62. (a) Secrist, J. A.; Shortnacy, A. T.; Montgomery, J. A. J. Med. Chem. 1988, 31, 405-410.
63. (b) Montgomery, J. A.; Shortnacy-Fowler, A. T.; Clayton, S. D.; Riordan, J. M.; Secrist, J. A. J. Med. Chem. 1992, 35, 397-401.
64. (c) Carson, D. A.; Wasson, D. B.; Esparza, L. M.; Carrera, C. J.; Kipps, T. J.; Cottam H. B. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 2970-2974.
65. (a) Watanabe, K. A.; Reichmen, U.; Hirota, K; Lopez, C.; Fox, J. J. J. Med. Chem. 1979, 22, 21-24.
66. (b) Watanabe, K. A.; Su, T.-L.; Klein, R. S.; Chu, C. K.; Matsuda, A.; Chun, M. W.; Lopez, C.; Fox, J. J. J. Med. Chem. 1983, 26, 152-156.
67. Burchenal, J. H.; Chou, T.-C.; Lokys, L.; Smith, R. S.; Watanabe, K. A.; Su, T.-L.; Fox, J. J. Cancer Res. 1982, 42, 2598-2600.
68. Jeong, L. S.; Nicklaus, M. C.; George, C.; Marquez, V. E. Tetrahedron Lett. 1994, 35, 7569-7572.
69. Hughes, N. A.; Kuhajda, K.-M.; Miljkovic, D. A. Carbohydr. Res. 1994, 257, 299-304.
70. Zhang, W.; Robins, M. J. Tetrahedron Lett. 1992, 33, 1177-1180.
71. The stereochemistry of 54 was determined by an NOE analysis: a 1.5% NOE at H-5a was observed when H-2 was irradiated.
72. Yoshimura, Y.; Kano, F.; Miyazaki, S.; Ashida, N.; Sakata, S.; Haraguchi, K.; Itoh, Y.; Tanaka, H.; Miyasaka, T. Nucleosides Nucleotides 1996, 15, 305-324.
73. The biological results of 4′-thioDMDC have been appeared: Miura, S.; Tanaka, M.; Yoshimura, Y.; Satoh, H.; Sakata, S.; Machida, H.; Matsuda, A.; Sasaki, T. Biol. Pharm. Bull. 1996, 19, 1311-1315.
74. 4′-ThioFAC administered i.p. daily for 8 consecutive days increased the life span of mice bearing P388 leukemia, showing T/C values of 163% and 205% at doses of 3 and 10 mg/kg/day, respectively. In the same assay, araC showed T/C values of 184% and 200% at doses of 3 and 10 mg/kg/day, respectively.
75. Mossman, T. J. Immunol. Methods 1983, 65, 55-63.
76. Finter, N. B. J. Gen. Viol. 1969, 5, 419-427.